Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Tony Hodges, MD

La Jolla Therapeutics

Disclosure(s): LaJolla Pharmaceutical: Chief Medical Officer, Stocks/Bonds

Poster(s):

1679 - Susceptibility of Gram-Negative Clinical Isolates Collected from the USA in 2020 to Eravacycline and Comparators
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET